Dabigatran-d3

• CAT Number: S000274
• CAS Number: 1246817-44-6
• Molecular Formula: C25H22D3N7O3
• Molecular Weight: 474.53
• Purity: ≥95%
• Target: Thrombin
• IUPAC Name: 3-[[2-[(4-carbamimidoylanilino)methyl]-1-(trideuteriomethyl)benzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid
• InChI: InChI=1S/C25H25N7O3/c1-31-20-10-7-17(25(35)32(13-11-23(33)34)21-4-2-3-12-28-21)14-19(20)30-22(31)15-29-18-8-5-16(6-9-18)24(26)27/h2-10,12,14,29H,11,13,15H2,1H3,(H3,26,27)(H,33,34)/i1D3
• InChIKey: YBSJFWOBGCMAKL-FIBGUPNXSA-N
• SMILES: CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N

Dabigatran-d3（Cat No.:S000274） is a deuterated version of dabigatran, where three hydrogen atoms are replaced with deuterium, improving its molecular stability. This modification makes it particularly useful as an internal standard for precise analytical methods like mass spectrometry and NMR spectroscopy. Dabigatran is an oral anticoagulant that inhibits thrombin, helping to prevent blood clots in conditions such as atrial fibrillation and following orthopedic surgeries. The introduction of deuterium into dabigatran-d3 allows for more detailed pharmacokinetic and metabolic studies, providing clearer insights into the drug’s behavior and efficacy within biological systems.